First-trimester prediction of birth weight

American Journal of Perinatology

Volumn 30, Issue 8, 2013, Pages 665-671

  Boucoiran, Isabelle ^a   Djemli, Anissa ^a   Taillefer, Catherine ^a   Rypens, Françoise ^a   Delvin, Edgard ^a   Audibert, François ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

birth weight; first trimester screening; free human chorionic gonadotropin; large for gestational age; nuchal translucency; pregnancy associated plasma protein A; small for gestational age

Indexed keywords

CHORIONIC GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

AGE; ANEUPLOIDY; ARTICLE; BIRTH WEIGHT; BODY WEIGHT; COHORT ANALYSIS; DOWN SYNDROME; ETHNICITY; FETUS; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; GESTATIONAL AGE; HUMAN; LARGE FOR GESTATIONAL AGE; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; SMOKING;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BIRTH WEIGHT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COHORT STUDIES; DOWN SYNDROME; FEMALE; GENETIC TESTING; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LINEAR MODELS; MALE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RETROSPECTIVE STUDIES;

EID: 84883135464     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0032-1331023     Document Type: Article

References (36)

1. Spencer K., Cowans N. J., Avgidou K., Molina F., Nicolaides K. H. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol: 2008; 31 15 19
2. Poon L. C., Karagiannis G., Staboulidou I., Shafiei A., Nicolaides K. H. Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates. Prenat Diagn: 2011; 31 58 65
3. Goetzinger K. R., Singla A., Gerkowicz S., Dicke J. M., Gray D. L., Odibo A. O. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol: 2009; 201 412, e1-e6
4. Plasencia W., González Dávila E., Tetilla V., Padrón Pérez E., García Hernández J. A., González González N. L. First-trimester screening for large-for-gestational-age infants. Ultrasound Obstet Gynecol: 2012; 39 389 395
5. Montanari L., Alfei A., Albonico G., et al. The impact of first-trimester serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A on the diagnosis of fetal growth restriction and small for gestational age infant. Fetal Diagn Ther: 2009; 25 130 135
6. Kagan K. O., Wright D., Baker A., Sahota D., Nicolaides K. H. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol: 2008; 31 618 624
7. Pedersen J. F., Sorensen S., Ruge S. Human placental lactogen and pregnancy-associated plasma protein A in first trimester and subsequent fetal growth. Acta Obstet Gynecol Scand: 1995; 74 505 508
8. Canini S., Prefumo F., Pastorino D., et al. Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril: 2008; 89 174 178
9. Leung T. Y., Sahota D. S., Chan L. W., et al. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester. Ultrasound Obstet Gynecol: 2008; 31 10 14
10. Tul N., Pusenjak S., Osredkar J., Spencer K., Novak-Antolic Z. Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A. Prenat Diagn: 2003; 23 990 996
11. Dugoff L., Hobbins J. C., Malone F. D., et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol: 2004; 191 1446 1451
12. Krantz D., Goetzl L., Simpson J. L., et al. First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol: 2004; 191 1452 1458
13. Boldt H. B., Conover C. A. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Horm IGF Res: 2007; 17 10 18
14. Lawrence J. B., Oxvig C., Overgaard M. T., et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A: 1999; 96 3149 3153
15. Fox H. Effect of hypoxia on trophoblast in organ culture. A morphologic and autoradiographic study. Am J Obstet Gynecol: 1970; 107 1058 1064
16. Kelekci S., Yilmaz B., Savan K., Sonmez S. Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus. J Obstet Gynaecol: 2005; 25 579 582
17. Cowans N. J., Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn: 2007; 27 264 271
18. Pihl K., Sorensen T. L., Norgaard-Pedersen B., et al. First-trimester combined screening for Down syndrome: prediction of low birth weight, small for gestational age and pre-term delivery in a cohort of non-selected women. Prenat Diagn: 2008; 28 247 253
19. Kuc S., Wortelboer E. J., Koster M. P., de Valk H. W., Schielen P. C., Visser G. H. Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation. BJOG: 2011; 118 748 754
20. Hadlock F. P., Shah Y. P., Kanon D. J., Lindsey J. V. Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real-time US. Radiology: 1992; 182 501 505
21. Kramer M. S., Platt R. W., Wen S. W., et al. Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics: 2001; 108 E35
22. Poon L. C., Karagiannis G., Stratieva V., Syngelaki A., Nicolaides K. H. First-trimester prediction of macrosomia. Fetal Diagn Ther: 2011; 29 139 147
23. Leung T. Y., Chan L. W., Leung T. N., Fung T. Y., Sahota D. S., Lau T. K. First-trimester maternal serum levels of placental hormones are independent predictors of second-trimester fetal growth parameters. Ultrasound Obstet Gynecol: 2006; 27 156 161
24. Pihl K., Larsen T., Krebs L., Christiansen M. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses. Prenat Diagn: 2008; 28 1131 1135
25. Morssink L. P., Kornman L. H., Hallahan T. W., et al. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn: 1998; 18 147 152
26. Ong C. YT, Liao A. W., Spencer K., Munim S., Nicolaides K. H. First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG: 2000; 107 1265 1270
27. Smith G. C., Stenhouse E. J., Crossley J. A., Aitken D. A., Cameron A. D., Connor J. M. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab: 2002; 87 1762 1767
28. Yaron Y., Ochshorn Y., Heifetz S., Lehavi O., Sapir Y., Orr-Urtreger A. First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagn Ther: 2002; 17 352 356
29. Smith G. C., Smith M. F., McNay M. B., Fleming J. E. First-trimester growth and the risk of low birth weight. N Engl J Med: 1998; 339 1817 1822
30. Burton G. J., Hempstock J., Jauniaux E. Nutrition of the human fetus during the first trimester-a review. Placenta: 2001; 22 Suppl A S70 S77
31. Brausewetter F., Jehle P. M., Jung M. F., et al. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF). Horm Metab Res: 2001; 33 713 720
32. Haak M. C., Bartelings M. M., Jackson D. G., Webb S., van Vugt J. M., Gittenberger-de Groot A. C. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod: 2002; 17 1086 1092
33. de Mooij Y. M., Bartelings M. M., Twisk J. WR., et al. Altered jugular vein and ductus venosus flow velocities in fetuses with increased nuchal translucency and distended jugular lymphatic sacs. Am J Obstet Gynecol: 2010; 202 566, e1-e8
34. Smith G. CS. First trimester origins of fetal growth impairment. Semin Perinatol: 2004; 28 41 50
35. Dickey R. P., Gasser R. F. Ultrasound evidence for variability in the size and development of normal human embryos before the tenth post-insemination week after assisted reproductive technologies. Hum Reprod: 1993; 8 331 337
36. Ericsson A., Säljö K., Sjöstrand E., et al. Brief hyperglycaemia in the early pregnant rat increases fetal weight at term by stimulating placental growth and affecting placental nutrient transport. J Physiol: 2007; 581 Pt 3 1323 1332